Mimicking the humoral immune response in vitro results in antigen‐specific isotype switching supported by specific autologous T helper cells: generation of human HIV‐1‐neutralizing IgG monoclonal antibodies from naive donors
- 1 March 1995
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 25 (3) , 657-663
- https://doi.org/10.1002/eji.1830250305
Abstract
Molecular and cellular requirements for antigen-specific isotype switch of human B cells have been investigated by mimicking signaling occurring in germinal centers. Peripheral blood mononuclear cells from healthy seronegative blood donors were first primary immunized in vitro, using a synthetic immunogen containing both a T and B cell epitope, which generated specific IgM-secreting B cells. We used the apex of the V3 loop of gp120 as B cell epitope linked to a promiscuous T helper epitope from tetanus toxin. In parallel, CD4+ T helper cell clones specific for the T epitope of the immunogen were established. In a secondary in vitro stimulation period, we co-cultured the antigen-specific T and B cells on CD32-transfected fibroblasts, together with an anti-CD40 monoclonal antibody. This resulted in isotype switching and human antigen-specific, IgG-secreting B cells were detected. This response was strictly dependent upon the presence of autologous T helper cells and the immunogen. Antigen-specific human B cells derived from this primary and secondary in vitro immunization were subsequently subjected to electrofield-induced somatic cell hybridization and hybridomas secreting human anti-V3 IgG monoclonal antibodies were isolated. One human antibody was further characterized and shown to be specific for the immunizing antigen with an affinity constant of 24 nM. This antibody also effectively neutralized different isolates of HIV-1, achieving a 50% neutralization at 0.46 μg/ml.Keywords
This publication has 22 references indexed in Scilit:
- Human Th0-type T Helper-Cell Clone Supports Antigen-Specific Immunoglobulin Production in Scid/beige-hu MiceScandinavian Journal of Immunology, 1994
- B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells.The Journal of Experimental Medicine, 1993
- Sites of B-cell activation in vivoCurrent Opinion in Immunology, 1993
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeCell, 1993
- Germinal centres in T-cell-dependent antibody responsesImmunology Today, 1992
- Differing Lymphokine Profiles of Functional Subsets of Human CD4 and CD8 T Cell ClonesScience, 1991
- Growing human B lymphocytes in the CD40 systemNature, 1991
- A new superfamily of cell surface proteins related to the nerve growth factor receptorImmunology Today, 1991
- Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40Science, 1991
- Human mAbs produced by primary in-vitro immunizationImmunology Today, 1988